Rocket


News + Filings
Transactions
Holdings





All
13F
13D/G
Other



CR Group L.P. Create: Alert

All | News | Filings
Date FiledTypeDescription
09/28/2023 4 CR Group L.P. (10% Owner) has filed a Form 4 on T2 Biosystems, Inc.
Txns: Sold 2,156,717 shares @ $0.2007, valued at $432.9k
Sold 1,343,011 shares @ $0.2007, valued at $269.5k
Sold 431,343 shares @ $0.2007, valued at $86.6k
Sold 1,461,849 shares @ $0.2007, valued at $293.4k
09/27/2023 4 CR Group L.P. (10% Owner) has filed a Form 4 on T2 Biosystems, Inc.
Txns: Sold 99,979 shares @ $0.25, valued at $25k
Sold 62,258 shares @ $0.25, valued at $15.6k
Sold 19,996 shares @ $0.25, valued at $5k
Sold 67,767 shares @ $0.25, valued at $16.9k
09/26/2023 4 CR Group L.P. (10% Owner) has filed a Form 4 on T2 Biosystems, Inc.
Txns: Sold 2,031,313 shares @ $0.2588, valued at $525.7k
Sold 1,264,920 shares @ $0.2588, valued at $327.4k
Sold 406,263 shares @ $0.2588, valued at $105.1k
Sold 1,376,848 shares @ $0.2588, valued at $356.3k
08/14/2023 SC 13G/A CR Group L.P. reports a 19.9% stake in Avinger, Inc.
08/09/2023 4 CR Group L.P. (10% Owner) has filed a Form 4 on Avinger Inc
Txns: Granted 166 convertible preferred @ $0.715, valued at $118.7
Granted 310 convertible preferred @ $0.715, valued at $221.4
Granted 658 convertible preferred @ $0.715, valued at $470.6
Granted 53 convertible preferred @ $0.715, valued at $38.2
Granted 733 convertible preferred @ $0.715, valued at $523.9
08/09/2023 3 CR Group L.P. (10% Owner) has filed a Form 3 on Avinger Inc
07/14/2023 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
07/13/2023 SC 13G CR Group L.P. reports a 19.9% stake in T2 Biosystems, Inc.
07/06/2023 4 CR Group L.P. (10% Owner) has filed a Form 4 on T2 Biosystems, Inc.
Txns: Granted 19,334,277 shares @ $0
Granted 12,039,660 shares @ $0
Granted 3,866,855 shares @ $0
Granted 13,105,006 shares @ $0
07/06/2023 3 CR Group L.P. (10% Owner) has filed a Form 3 on T2 Biosystems, Inc.
01/06/2021 SC 13G/A CR Group L.P. reports a 0.3% stake in Assertio Holdings, Inc.
12/30/2020 SC 13G/A CR Group L.P. reports a 5.6% stake in Assertio Holdings, Inc.
12/29/2020 4 CR Group L.P. (10% Owner) has filed a Form 4 on Assertio Holdings, Inc.
Txns: Sold 6,784,334 shares @ $0.3745, valued at $2.5M
Sold 1,982,851 shares @ $0.3682, valued at $730.1k
12/22/2020 4 CR Group L.P. (10% Owner) has filed a Form 4 on Assertio Holdings, Inc.
Txns: Sold 500,000 shares @ $0.3776, valued at $188.8k
Sold 500,000 shares @ $0.3602, valued at $180.1k
Sold 1,500,000 shares @ $0.339, valued at $508.5k
07/06/2020 3 Form 3 - Initial statement of beneficial ownership of securities:
06/09/2020 SC 13D/A Capital Royalty L.P. reports a 48.5% stake in TEARLAB CORPORATION
05/28/2020 3 CR Group L.P. (10% Owner) has filed a Form 3 on Assertio Holdings, Inc.
05/28/2020 SC 13G Capital Royalty L.P. reports a 15.8% stake in Assertio Holdings, Inc.
05/22/2020 4 CR Group L.P. (10% Owner) has filed a Form 4 on Zyla Life Sciences
Txns: Disposed/sold 4,586,874 shares @ $0
Disposed/sold 2,436,459 warrants @ $0.0001, valued at $243.6
05/22/2020 SC 13D/A Capital Royalty L.P. reports a 0% stake in Zyla Life Sciences
05/21/2020 SC 13D Capital Royalty L.P. reports a 48.5% stake in TEARLAB CORPORATION
02/13/2020 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/13/2020 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
10/02/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/02/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/02/2019 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
07/03/2019 4 Capital Royalty L.P. (10% Owner) has filed a Form 4 on Zyla Life Sciences
Txns: Disposed of 4,586,874 shares @ $0
Acquired 4,586,874 shares @ $0
Disposed of 2,436,459 warrants @ $0.0001, valued at $243.6
Acquired 2,436,459 warrants @ $0.0001, valued at $243.6
02/11/2019 3 Form 3 - Initial statement of beneficial ownership of securities:
12/28/2018 SC 13G Capital Royalty L.P. reports a 5.6% stake in Strongbridge Biopharma plc
11/20/2018 SC 13D/A Capital Royalty L.P. reports a 39.8% stake in § 240. Valeritas Holdings, Inc.
11/20/2018 4 Capital Royalty L.P. (10% Owner) has filed a Form 4 on Valeritas Holdings Inc.
Txns: Bought 4,224,605 shares @ $0
Bought 1,264,997 shares @ $0
Bought 7,427,065 shares @ $0
Bought 2,083,333 shares @ $0
Bought 4,224,605 options to buy @ $0.6, valued at $2.5M
Bought 1,264,997 options to buy @ $0.6, valued at $759k
Bought 7,427,065 options to buy @ $0.6, valued at $4.5M
Bought 2,083,333 options to buy @ $0.6, valued at $1.2M
Bought 4,224,605 options to buy @ $0.48, valued at $2M
Bought 1,264,997 options to buy @ $0.48, valued at $607.2k
Bought 7,427,065 options to buy @ $0.48, valued at $3.6M
04/07/2017 SC 13D Form SC 13D - General statement of acquisition of beneficial ownership:
03/30/2017 4 Capital Royalty L.P. (10% Owner) has filed a Form 4 on Valeritas Holdings Inc.
Txns: Bought 437,836 shares @ $10, valued at $4.4M
Bought 154,727 shares @ $10, valued at $1.5M
Bought 490,234 shares @ $10, valued at $4.9M
Bought 2,116,803 shares @ $10, valued at $21.2M
Bought 800,400 shares @ $10, valued at $8M
03/30/2017 3/A Capital Royalty L.P. (10% Owner) has filed a Form 3/A on Valeritas Holdings Inc.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy